Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21


Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease.

Bedsaul JR, Carter NM, Deibel KE, Hutcherson SM, Jones TA, Wang Z, Yang C, Yang YK, Pomerantz JL.

Front Immunol. 2018 Sep 19;9:2105. doi: 10.3389/fimmu.2018.02105. eCollection 2018. Review.


Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11).

Dadi H, Jones TA, Merico D, Sharfe N, Ovadia A, Schejter Y, Reid B, Sun M, Vong L, Atkinson A, Lavi S, Pomerantz JL, Roifman CM.

J Allergy Clin Immunol. 2018 May;141(5):1818-1830.e2. doi: 10.1016/j.jaci.2017.06.047. Epub 2017 Aug 19.


Correction for Pedersen et al., Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181.

Pedersen SM, Chan W, Jattani RP, Mackie dS, Pomerantz JL.

Mol Cell Biol. 2016 Mar 31;36(8):1322. doi: 10.1128/MCB.00106-16. Print 2016 Apr. No abstract available.


Cooperative Control of Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling by an Unusual Array of Redundant Repressive Elements.

Jattani RP, Tritapoe JM, Pomerantz JL.

J Biol Chem. 2016 Apr 15;291(16):8324-36. doi: 10.1074/jbc.M115.683714. Epub 2016 Feb 16.


Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain.

Jattani RP, Tritapoe JM, Pomerantz JL.

J Biol Chem. 2016 Apr 15;291(16):8338-48. doi: 10.1074/jbc.M116.717322. Epub 2016 Feb 16.


NK Cell Maturation and Cytotoxicity Are Controlled by the Intramembrane Aspartyl Protease SPPL3.

Hamblet CE, Makowski SL, Tritapoe JM, Pomerantz JL.

J Immunol. 2016 Mar 15;196(6):2614-26. doi: 10.4049/jimmunol.1501970. Epub 2016 Feb 5.


Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181.

Pedersen SM, Chan W, Jattani RP, Mackie dS, Pomerantz JL.

Mol Cell Biol. 2015 Dec 28;36(5):794-808. doi: 10.1128/MCB.00876-15. Erratum in: Mol Cell Biol. 2016 Apr;36(8):1322.


A protease-independent function for SPPL3 in NFAT activation.

Makowski SL, Wang Z, Pomerantz JL.

Mol Cell Biol. 2015 Jan;35(2):451-67. doi: 10.1128/MCB.01124-14. Epub 2014 Nov 10.


Efficacy of the bilateral ilioinguinal-iliohypogastric block with intrathecal morphine for postoperative cesarean delivery analgesia.

Vallejo MC, Steen TL, Cobb BT, Phelps AL, Pomerantz JM, Orebaugh SL, Chelly JE.

ScientificWorldJournal. 2012;2012:107316. doi: 10.1100/2012/107316. Epub 2012 Dec 4.


A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival.

Chan W, Schaffer TB, Pomerantz JL.

Mol Cell Biol. 2013 Jan;33(2):429-43. doi: 10.1128/MCB.00850-12. Epub 2012 Nov 12.


Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cells.

Szeto GL, Pomerantz JL, Graham DR, Clements JE.

J Biol Chem. 2011 Apr 1;286(13):11275-82. doi: 10.1074/jbc.M110.210518. Epub 2011 Jan 31.


The dynamic distribution of CARD11 at the immunological synapse is regulated by the inhibitory kinesin GAKIN.

Lamason RL, Kupfer A, Pomerantz JL.

Mol Cell. 2010 Dec 10;40(5):798-809. doi: 10.1016/j.molcel.2010.11.007.


Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain.

Lamason RL, McCully RR, Lew SM, Pomerantz JL.

Biochemistry. 2010 Sep 28;49(38):8240-50. doi: 10.1021/bi101052d.


Transcriptional target-based expression cloning of immunoregulatory molecules.

Lamason RL, Lew SM, Pomerantz JL.

Immunol Res. 2010 Jul;47(1-3):172-8. doi: 10.1007/s12026-009-8148-z. Review.


Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation.

Yang HC, Shen L, Siliciano RF, Pomerantz JL.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6321-6. doi: 10.1073/pnas.0809536106. Epub 2009 Mar 31.


Phosphorylation of the CARMA1 linker controls NF-kappaB activation.

Sommer K, Guo B, Pomerantz JL, Bandaranayake AD, Moreno-GarcĂ­a ME, Ovechkina YL, Rawlings DJ.

Immunity. 2005 Dec;23(6):561-74.


Two pathways to NF-kappaB.

Pomerantz JL, Baltimore D.

Mol Cell. 2002 Oct;10(4):693-5.


CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex.

Pomerantz JL, Denny EM, Baltimore D.

EMBO J. 2002 Oct 1;21(19):5184-94.

Supplemental Content

Loading ...
Support Center